Respiratory Research (Mar 2012)

T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease

  • Kaur Manminder,
  • Smyth Lucy JC,
  • Cadden Paul,
  • Grundy Seamus,
  • Ray David,
  • Plumb Jonathan,
  • Singh Dave

DOI
https://doi.org/10.1186/1465-9921-13-20
Journal volume & issue
Vol. 13, no. 1
p. 20

Abstract

Read online

Abstract Background There are increased numbers of activated lymphocytes in the lungs of chronic obstructive pulmonary disease (COPD) patients. The clinical benefits of corticosteroids in COPD patients are limited. Our hypothesis is that lymphocytes play a role in this corticosteroid insensitivity. Objectives To investigate the effects of the corticosteroid dexamethasone on lung lymphocyte cytokine production from patients with COPD compared to controls. Methods Cultured airway lymphocytes obtained by bronchoscopy from healthy non-smokers (HNS), smokers (S) and COPD patients were stimulated with phytohaemagglutinin (PHA) & phorbol myristate acetate (PMA), +/- dexamethasone. Supernatants were assayed for interleukin (IL)-2 and interferon (IFN)γ. Immunofluoresence was used to analyse changes in CD8 glucocorticoid receptor (GRα and GRβ) expression. Results The inhibition of PHA/PMA stimulated IFNγ production by dexamethasone was reduced in COPD patients compared to HNS (p p Conclusions IFNγ production from COPD airway lymphocytes is corticosteroid insensitive. This phenomenon may be important in the poor clinical response often observed with corticosteroids.

Keywords